Mark Zalupski

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Contessa Joseph N; Griffith Kent A; Wolff Elizabeth; Ensminger William; Zalupski Mark; Lawrence Theodore S; Ben-Josef Edgar
Radiotherapy for pancreatic neuroendocrine tumors.
Bekaii-Saab Tanios; Markowitz Joseph; Prescott Nichole; Sadee Wolfgang; Heerema Nyla; Wei Lai; Dai Zunyan; Papp Audrey; Campbell Angela; Culler Kristy; Balint Catherine; O'Neil Bert; Lee Ruey-Min; Zalupski Mark; Dancey Janet; Chen Helen; Grever Michael; Eng Charis; Villalona-Calero Miguel
A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas.
Gartner Elaina M; Griffith Kent A; Pan Quintin; Brewer George J; Henja Gwen F; Merajver Sofia D; Zalupski Mark M
A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Mark Zalupski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Contessa Joseph N; Griffith Kent A; Wolff Elizabeth; Ensminger William; Zalupski Mark; Lawrence Theodore S; Ben-Josef Edgar
Radiotherapy for pancreatic neuroendocrine tumors.
International journal of radiation oncology, biology, physics 2009;75(4):1196-200.
2009: Bekaii-Saab Tanios; Markowitz Joseph; Prescott Nichole; Sadee Wolfgang; Heerema Nyla; Wei Lai; Dai Zunyan; Papp Audrey; Campbell Angela; Culler Kristy; Balint Catherine; O'Neil Bert; Lee Ruey-Min; Zalupski Mark; Dancey Janet; Chen Helen; Grever Michael; Eng Charis; Villalona-Calero Miguel
A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5895-901.
2009: Gartner Elaina M; Griffith Kent A; Pan Quintin; Brewer George J; Henja Gwen F; Merajver Sofia D; Zalupski Mark M
A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer.
Investigational new drugs 2009;27(2):159-65.
2008: Small William; Berlin Jordan; Freedman Gary M; Lawrence Theodore; Talamonti Mark S; Mulcahy Mary F; Chakravarthy A Bapsi; Konski Andre A; Zalupski Mark M; Philip Philip A; Kinsella Timothy J; Merchant Nipun B; Hoffman John P; Benson Al B; Nicol Steven; Xu Rong M; Gill John F; McGinn Cornelius J
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):942-7.
2008: El-Rayes Bassel F; Zalupski Mark M; Manza Stephanie G; Rusin Barbara; Ferris Ann Marie; Vaishampayan Ulka; Heilbrun Lance K; Venkatramanamoorthy Raghu; Shields Anthony F; Philip Philip A
Phase-II study of dose attenuated schedule of irinotecan, capecitabine, and celecoxib in advanced colorectal cancer.
Cancer chemotherapy and pharmacology 2008;61(2):283-9.
2007: Ben-Josef Edgar; Lawrence Theodore S; Zalupski Mark M
Radiotherapy for locally advanced pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4861.
2007: Desai Sameer P; Ben-Josef Edgar; Normolle Daniel P; Francis Isaac R; Greenson Joel K; Simeone Diane M; Chang Alfred E; Colletti Lisa M; Lawrence Theodore S; Zalupski Mark M
Phase I study of oxaliplatin, full-dose gemcitabine, and concurrent radiation therapy in pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4587-92.
2007: Desai Sameer P; El-Rayes Basil F; Ben-Josef Edgar; Greenson Joel K; Knol James A; Huang Emina H; Griffith Kent A; Philip Philip A; McGinn Cornelius J; Zalupski Mark M
A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer.
American journal of clinical oncology 2007;30(4):340-5.
2007: Schneider Bryan J; El-Rayes Basil; Muler Jeffery H; Philip Philip A; Kalemkerian Gregory P; Griffith Kent A; Zalupski Mark M
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site.
Cancer 2007;110(4):770-5.
2007: Ciuleanu T; Diculescu M; Hoepffner N M; Trojan J; Sailer V; Zalupski M; Herrmann T; Roth A; Chick J; Brock K; Albert D; Philip P A
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers.
Investigational new drugs 2007;25(4):385-90.
2007: Murphy James D; Adusumilli Saroja; Griffith Kent A; Ray Michael E; Zalupski Mark M; Lawrence Theodore S; Ben-Josef Edgar
Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer.
International journal of radiation oncology, biology, physics 2007;68(3):801-8.
2007: Chugh Rashmi; Wagner Thomas; Griffith Kent A; Taylor Jeremy M G; Thomas Dafydd G; Worden Francis P; Leu Kirsten M; Zalupski Mark M; Baker Laurence H
Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma.
Cancer 2007;109(11):2315-22.
2007: El-Rayes Basil F; Zalupski Mark; Shields Anthony F; Manza Stephanie G; LoRusso Patricia; Philip Philip A
A phase I study of gemcitabine and uracil-ftorfar (UFT)/leucovorin.
American journal of clinical oncology 2007;30(2):101-5.
2006: Ben-David Merav A; Griffith Kent A; Abu-Isa Eyad; Lawrence Theodore S; Knol James; Zalupski Mark; Ben-Josef Edgar
External-beam radiotherapy for localized extrahepatic cholangiocarcinoma.
International journal of radiation oncology, biology, physics 2006;66(3):772-9.
2006: Bekaii-Saab Tanios S; Mortazavi Amir; Hicks Lee G; Zalupski Mark; Pelley Robert J; Chan Kenneth K; Kraut Eric H
A phase II study of chloroquinoxaline sulfonamide (CQS) in patients with metastatic colorectal carcinoma (MCRC).
Investigational new drugs 2006;24(4):343-6.
2006: Von Burton Gary; Rankin Cathy; Zalupski Mark M; Mills Glen M; Borden Ernest C; Karen Antman
Phase II trial of gemcitabine as first line chemotherapy in patients with metastatic or unresectable soft tissue sarcoma.
American journal of clinical oncology 2006;29(1):59-61.
2006: Talamonti Mark S; Small William; Mulcahy Mary F; Wayne Jeffrey D; Attaluri Vikram; Colletti Lisa M; Zalupski Mark M; Hoffman John P; Freedman Gary M; Kinsella Timothy J; Philip Philip A; McGinn Cornelius J
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma.
Annals of surgical oncology 2006;13(2):150-8.
2005: El-Rayes Basil F; Zalupski Mark M; Shields Anthony F; Ferris Ann Marie; Vaishampayan Ulka; Heilbrun Lance K; Venkatramanamoorthy Raghu; Adsay Volkan; Philip Philip A
A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancer.
Investigational new drugs 2005;23(6):583-90.
2005: Schneider Bryan J; Ben-Josef Edgar; McGinn Cornelius J; Chang Alfred E; Colletti Lisa M; Normolle Daniel P; Hejna Gwen F; Lawrence Theodore S; Zalupski Mark M
Capecitabine and radiation therapy preceded and followed by combination chemotherapy in advanced pancreatic cancer.
International journal of radiation oncology, biology, physics 2005;63(5):1325-30.
2005: Leichman Cynthia G; Benedetti Jacqueline K; Zalupski Mark M; Hochster Howard; Shields Anthony F; Lenz Heinz-Josef; Wade Iii James L; Bearden Iii James D; Macdonald John S
Assessment of infusional 5-fluorouracil schedule and dose intensity: a Southwest Oncology Group and Eastern Cooperative Oncology Group study.
Clinical colorectal cancer 2005;5(2):119-23.
2005: Chugh Rashmi; Dunn Rodney; Zalupski Mark M; Biermann J Sybil; Sondak Vernon K; Mace Joseph R; Leu Kirsten M; Chandler William F; Baker Laurence H
Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3597-604.
2005: El-Rayes Basil F; Shields Anthony F; Zalupski Mark; Heilbrun Lance K; Jain Vikash; Terry Damita; Ferris Ann Marie; Philip Philip A
A phase II study of carboplatin and paclitaxel in adenocarcinoma of unknown primary.
American journal of clinical oncology 2005;28(2):152-6.
2005: Worden Francis P; Taylor Jeremy M G; Biermann Janet S; Sondak Vernon K; Leu Kirstin M; Chugh Rashmi; McGinn Cornelius J; Zalupski Mark M; Baker Laurence H
Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(1):105-12.
2005: El-Rayes Basil F; Ibrahim Dina; Shields Anthony F; LoRusso Patricia M; Zalupski Mark M; Philip Philip A
Phase I study of liposomal doxorubicin (Doxil) and cyclophosphamide in solid tumors.
Investigational new drugs 2005;23(1):57-62.
2004: Allen Aaron M; Zalupski Mark M; Robertson John M; Eckhauser Frederic E; Simone Diane; Brown Diane; Hejna Gwen; Normolle Daniel; Lawrence Theodore S; McGinn Cornelius J
Adjuvant therapy in pancreatic cancer: Phase I trial of radiation dose escalation with concurrent full-dose gemcitabine.
International journal of radiation oncology, biology, physics 2004;59(5):1461-7.
2004: El-Rayes B F; Shields A; Zalupski M; Heilbrun L K; Jain V; Terry D; Ferris A; Philip P A
A phase II study of carboplatin and paclitaxel in esophageal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(6):960-5.
2004: Leu Kirsten M; Ostruszka Leo J; Shewach Donna; Zalupski Mark; Sondak Vernon; Biermann J Sybil; Lee Julia Shin-Jung; Couwlier Carol; Palazzolo Krisinda; Baker Laurence H
Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1706-12.
2004: Zalupski Mark M; Rankin Cathryn; Ryan James R; Lucas David R; Muler Jeffrey; Lanier Keith S; Budd George Thomas; Biermann J Sybil; Meyers Frederick J; Antman Karen
Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.
Cancer 2004;100(4):818-25.
2004: Shields Anthony F; Zalupski Mark M; Marshall John L; Meropol Neal J
Treatment of advanced colorectal carcinoma with oxaliplatin and capecitabine: a phase II trial.
Cancer 2004;100(3):531-7.
2004: Muler Jeffrey H; McGinn Cornelius J; Normolle Daniel; Lawrence Theodore; Brown Diane; Hejna Gwen; Zalupski Mark M
Phase I trial using a time-to-event continual reassessment strategy for dose escalation of cisplatin combined with gemcitabine and radiation therapy in pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(2):238-43.
2003: Al-Sukhun Sana; Zalupski Mark M; Ben-Josef Edgar; Vaitkevicius Vainutis K; Philip Philip A; Soulen Renate; Weaver Donald; Adsay Volkan; Heilbrun Lance K; Levin Kenneth; Forman Jeffery D; Shields Anthony F
Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
American journal of clinical oncology 2003;26(6):543-9.
2003: Ammori John B; Colletti Lisa M; Zalupski Mark M; Eckhauser Frederic E; Greenson Joel K; Dimick Justin; Lawrence Theodore S; McGinn Cornelius J
Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2003;7(6):766-72.
2003: El-Rayes B F; Zalupski M M; Shields A F; Vaishampayan U; Heilbrun L K; Jain V; Adsay V; Day J; Philip P A
Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2920-5.
2003: Gadgeel S M; Boinpally R R; Heilbrun L K; Wozniak A; Jain V; Redman B; Zalupski M; Wiegand R; Parchment R; LoRusso P M
A phase I clinical trial of spicamycin derivative KRN5500 (NSC 650426) using a phase I accelerated titration "2B" design.
Investigational new drugs 2003;21(1):63-74.
2003: Gadgeel Shirish M; Shields Anthony F; Heilbrun Lance K; Labadidi Samir; Zalupski Mark; Chaplen Ruth; Philip Philip A
Phase II study of paclitaxel and carboplatin in patients with advanced gastric cancer.
American journal of clinical oncology 2003;26(1):37-41.
2003: McGinn Cornelius J; Zalupski Mark M
Radiation therapy with once-weekly gemcitabine in pancreatic cancer: current status of clinical trials.
International journal of radiation oncology, biology, physics 2003;56(4 Suppl):10-5.
2002: Muler Jeffrey H; Baker Laurence; Zalupski Mark M
Gastrointestinal stromal tumors: chemotherapy and imatinib.
Current oncology reports 2002;4(6):499-503.
2002: McGinn Cornelius J; Lawrence Theodore S; Zalupski Mark M
On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer.
Cancer 2002;95(4 Suppl):933-40.
2002: Symon Zvi; Davis Mary; McGinn Cornelius J; Zalupski Mark M; Lawrence Theodore S
Concurrent chemoradiotherapy with gemcitabine and cisplatin for pancreatic cancer: from the laboratory to the clinic.
International journal of radiation oncology, biology, physics 2002;53(1):140-5.
2002: LoRusso Patricia M; Prakash Sucharu; Wozniak Antoinette; Flaherty Lawrence; Zalupski Mark; Shields Anthony; Sands Howard; Parchment Ralph; Jasti Bhaskara
Phase I clinical trial of 5-fluoro-pyrimidinone (5FP), an oral prodrug of 5-fluorouracil (5FU).
Investigational new drugs 2002;20(1):63-71.
2001: McGinn C J; Zalupski M M; Shureiqi I; Robertson J M; Eckhauser F E; Smith D C; Brown D; Hejna G; Strawderman M; Normolle D; Lawrence T S
Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(22):4202-8.
2001: Philip P A; Zalupski M M; Vaitkevicius V K; Arlauskas P; Chaplen R; Heilbrun L K; Adsay V; Weaver D; Shields A F
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinoma.
Cancer 2001;92(3):569-77.
2001: McGinn C J; Zalupski M M
Combined-modality therapy in pancreatic cancer: current status and future directions.
Cancer journal (Sudbury, Mass.) 2001;7(4):338-48.
2001: Shields A F; Lange L M; Zalupski M M
Phase II study of liposomal doxorubicin in patients with advanced colorectal cancer.
American journal of clinical oncology 2001;24(1):96-8.
2001: Zonder J A; Shields A F; Zalupski M; Chaplen R; Heilbrun L K; Arlauskas P; Philip P A
A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(1):38-42.
2001: Prakash S; Foster B J; Meyer M; Wozniak A; Heilbrun L K; Flaherty L; Zalupski M; Radulovic L; Valdivieso M; LoRusso P M
Chronic oral administration of CI-994: a phase 1 study.
Investigational new drugs 2001;19(1):1-11.
2000: Ahmed S; Vaitkevicius V K; Zalupski M M; Du W; Arlauskas P; Gordon C; Kellogg C; Shields A F
Cisplatin, cytarabine, caffeine, and continuously infused 5-fluorouracil (PACE) in the treatment of advanced pancreatic carcinoma: a phase II study.
American journal of clinical oncology 2000;23(4):420-4.
1999: Jimenez R E; Zalupski M M; Frank J J; Du W; Ryan J R; Lucas D R
Multidrug resistance phenotype in high grade soft tissue sarcoma: correlation of P-glycoprotein immunohistochemistry with pathologic response to chemotherapy.
Cancer 1999;86(6):976-81.
1999: Lucas D R; Fletcher C D; Adsay N V; Zalupski M M
High-grade extraskeletal myxoid chondrosarcoma: a high-grade epithelioid malignancy.
Histopathology 1999;35(3):201-8.
1999: Leichman C G; Jacobson J R; Modiano M; Daniels J R; Zalupski M M; Doroshow J H; Fletcher W S; Macdonald J S
Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma: A Southwest Oncology Group pilot trial.
Cancer 1999;86(5):775-81.
1999: Philip P A; Ibrahim D; Zalupski M; Arlauskas P; Shields A
Gemcitabine and UFT plus oral calcium folinate: phase I study.
Oncology (Williston Park, N.Y.) 1999;13(7 Suppl 3):116-9.
1999: Shields A F; Philip P A; LoRusso P M; Ferris A M; Zalupski M M
Phase II study of CI-958 in colorectal cancer.
Cancer chemotherapy and pharmacology 1999;43(2):162-4.
1998: Zalupski M M; Shields A F; Philip P A; Kraut M; LoRusso P; Heilbrun L K; Vaitkevicius V
Evaluation of pyrazoloacridine in patients with advanced pancreatic carcinoma.
Investigational new drugs 1998;16(1):93-6.
1997: Philip P A; Zalupski M M; Gadgeel S; Hussain M; Shields A
A phase II study of carboplatin and paclitaxel in the treatment of patients with advanced esophageal and gastric cancer.
Seminars in oncology 1997;24(6 Suppl 19):S19-86-S19-88.
1997: Varterasian M; Zalupski M; Karanes C
The heterogeneity of leukemia occurring after treatment for sarcoma.
American journal of clinical oncology 1997;20(6):585-6.
1997: Mohamed A N; Zalupski M M; Ryan J R; Koppitch F; Balcerzak S; Kempf R; Wolman S R
Cytogenetic aberrations and DNA ploidy in soft tissue sarcoma. A Southwest Oncology Group Study.
Cancer genetics and cytogenetics 1997;99(1):45-53.
1997: Kunikane H; Zalupski M M; Ramachandran C; KuKuruga M A; Lucas D; Ryan J R; Krishan A
Flow cytometric analysis of P-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas.
Cytometry 1997;30(4):197-203.
1997: Zalupski M M; Philip P A; LoRusso P; Shields A F
Phase II study of pyrazoloacridine in patients with advanced colorectal carcinoma.
Cancer chemotherapy and pharmacology 1997;40(3):225-7.
1996: Lucas D R; Ryan J R; Zalupski M M; Gross M L; Ravindranath Y; Ortman B
Primary embryonal rhabdomyosarcoma of long bone. Case report and review of the literature.
The American journal of surgical pathology 1996;20(2):239-44.
1996: Hicks L G; Balcerzak S P; Zalupski M
GM-CSF did not allow doxorubicin dose escalation in the MAID regimen: a phase I trial. A Southwest Oncology Group study.
Cancer investigation 1996;14(6):507-12.
1996: Foster B J; LoRusso P M; Poplin E; Zalupski M; Valdivieso M; Wozniak A; Flaherty L; Kasunic D A; Earhart R H; Baker L H
Phase I trial of Adozelesin using the treatment schedule of daily x5 every 3 weeks.
Investigational new drugs 1996;13(4):321-6.
1996: Leichman C G; Poplin E; Zalupski M; Garcia Y; Grant A; Angeles A; DeJong L; Leichman L
A pilot trial of continuous infusion 5-fluorouracil with levamisole for adjuvant therapy of colon cancer.
The Journal of infusional chemotherapy 1996;6(2):84-6.
1996: Baker L H; Zalupski M
Sarcomas: the role of adjuvant chemotherapy and a proposed new staging system.
Monographs in pathology 1996;38():240-51.
1995: Redman B G; Chou T H; Zalupski M; Uberti J; Flaherty L; Dan M; Sensenbrenner L
Phase I trial of sequential cyclophosphamide, cyclosporin A, and interferon-alpha in patients with cancer: attempt to induce autologous graft-versus-host reaction to elicit an antitumor response.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1995;18(2):115-8.
1995: Zalupski M M; Baker L H
Systemic adjuvant chemotherapy for soft tissue sarcomas.
Hematology/oncology clinics of North America 1995;9(4):787-800.
1995: Altungoz O; Meloni A M; Peier A; Zalupski M; Spanier S; Brooks J S; Sandberg A A
Deletion 6q in three cases of mixed-type liposarcoma in addition to t(12;16)(q13;p11)
Cancer genetics and cytogenetics 1995;79(2):104-10.
1995: Zalupski M M; Baker L H
Low-dose, continuous infusion 5-fluorouracil and oral etoposide for the treatment of advanced sarcomas.
The Journal of infusional chemotherapy 1995;5(3):129-31.
1994: Blair S C; Zalupski M M; Baker L H
Ifosfamide and etoposide in the treatment of advanced soft tissue sarcomas.
American journal of clinical oncology 1994;17(6):480-4.
1994: Ozisik Y Y; Meloni A M; Peier A; Altungoz O; Spanier S S; Zalupski M M; Leong S P; Sandberg A A
Cytogenetic findings in 19 malignant bone tumors.
Cancer 1994;74(8):2268-75.
1994: Momin F A; Zalupski M; Heilbrun L K; Flaherty L; Fyfe G; Baker L H; Redman B G
Phase II trial of recombinant human macrophage colony-stimulating factor in metastatic soft tissue sarcoma.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;16(3):224-8.
1993: Zalupski M M; Ryan J R; Ensley J F; Maciorowski Z; Pietraszkiewicz H; Hussein M E; Kukuruga M; Sundareson A S; Baker L H
Development and optimization of tissue preparative methodology for DNA content analysis of soft tissue neoplasms.
Cytometry 1993;14(8):922-30.
1993: Zalupski M M; Benedetti J; Balcerzak S P; Hutchins L F; Belt R J; Hantel A; Goodwin J W
Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas. A Southwest Oncology Group study.
Investigational new drugs 1993;11(4):337-41.
1993: Ozisik Y Y; Meloni A M; Zalupski M M; Ryan J R; Qureshi F; Sandberg A A
Deletion of chromosome 13 in osteosarcoma secondary to irradiation.
Cancer genetics and cytogenetics 1993;69(1):35-7.
1993: Zalupski M M; Maciorowski Z; Ryan J R; Ensley J F; Hussein M E; Sundareson A S; Baker L H
DNA content parameters of paraffin-embedded soft tissue sarcomas: optimization of retrieval technique and comparison to fresh tissue.
Cytometry 1993;14(3):327-33.
1991: Zalupski M; Metch B; Balcerzak S; Fletcher W S; Chapman R; Bonnet J D; Weiss G R; Ryan J; Benjamin R S; Baker L H
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study.
Journal of the National Cancer Institute 1991;83(13):926-32.
1990: Zalupski M M; Ensley J F; Ryan J; Selvaggi S; Baker L H; Wolman S R
A common cytogenetic abnormality and DNA content alterations in dedifferentiated chondrosarcoma.
Cancer 1990;66(6):1176-82.
1990: Zalupski M; Ryan J R; Ensley J; Baker L
Cellular yields and DNA content parameters in osteogenic sarcomas.
La Chirurgia degli organi di movimento 1990;75(1 Suppl):15-7.
1988: Zalupski M; Baker L H
Ifosfamide.
Journal of the National Cancer Institute 1988;80(8):556-66.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Mark Zalupski

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Mark Zalupski (preview)

All Publications